Hypercoagulability Evaluation in Antiphospholipid Syndrome without Anticoagulation Treatment with Thrombin Generation Assay: A Preliminary Study

Hypercoagulability Evaluation in Antiphospholipid Syndrome without Anticoagulation Treatment with Thrombin Generation Assay: A Preliminary Study

Antiphospholipid syndrome (APS) is associated with thrombotic events (tAPS) and/or obstetrical morbidity (oAPS), with persisting antiphospholipid antibodies (aPL). Despite an update of aPL in 2006, several patients had typical clinical events without the classical biological criteria. The aim of our...

Full description

Bibliographic Details
Main Authors: Paul Billoir, Sébastien Miranda, Herve Levesque, Ygal Benhamou, Véronique Le Cam Duchez
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Clinical Medicine
Subjects:
antiphospholipid syndrome
thrombin generation assay
hypercoagulability
activated protein C resistance
Online Access:https://www.mdpi.com/2077-0383/10/12/2728

Similar Items

Similar Items